Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, March 21, 2023.
Talis Biomedical Corporation - common stock (NASDAQ:TLIS)
Strong Downtrend (-100) - TLIS is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, TLIS continues to fall. Traders should use caution and set stops.
Is it time to buy, sell, or avoid TLIS?
MarketClub looks at technical strength and momentum to determine if the timing is right for TLIS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for TLIS
The long-term trend has been DOWN since Feb 17th, 2021 at 23.0100
The intermediate-term trend has been DOWN since Feb 17th, 2023 at 0.5757
The short-term trend has been DOWN since Mar 17th, 2023 at 0.5600
Smart Scan Analysis for TLIS
Based on our trend formula, TLIS is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.52 | 0.52 | 0.52 | 0.52 | 0.00 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.52 | 213 | 2023-03-21 09:31:36 |
| 52wk High | 1.8 | 52wk High Date | 2022-03-23 |
| 52wk Low | 0.421 | 52wk Low Date | 2022-12-30 |
| Average Volume | 77,527 | Shares Outstanding | 26,782 |
| Assets | 194,094,000M | Liabilities | 41,708,000M |
| P/E Ratio | -0.18730000 |